Bagegni receives National Cancer Institute award
Medical oncologist has been awarded a 2024 Early Career Cancer Clinical Investigator Award
Nusayba Bagegni, MD, is an associate professor of medicine at Washington University School of Medicine in St. Louis.
Nusayba Bagegni, MD, an associate professor of medicine at Washington University School of Medicine in St. Louis, has been awarded a 2024 Early Career Cancer Clinical Investigator Award from the National Cancer Institute (NCI). The award, given to 10 researchers nationally, recognizes outstanding clinical investigators at NCI-designated cancer centers who demonstrate a commitment to academic clinical research, including NCI-funded clinical trials.
A board-certified medical oncologist, Bagegni treats patients with breast cancer at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine. She serves as associate medical director of clinical research in the Division of Oncology and the breast cancer clinical trials portfolio leader and has led several clinical trials in early-stage and advanced breast cancer. Bagegni has a particular research interest in aggressive breast cancer subtypes, breast cancer in younger women, metastatic breast cancer and developmental therapeutics.
Read more on the Siteman Cancer Center website.
